Method of preparing an undifferentiated cell

Details Method of preparing an undifferentiated cell Method of preparing an undifferentiated cell

2002-05-16

2008-08-12

Canella, Karen A. (Department: 1643)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S377000

Reexamination Certificate

active

07410773

ABSTRACT:
A method of increasing the relative number of cells expressing one or more stem cell markers in a cell population including committed cells is described. The method comprises: i. contacting the cell population with an agent that operably engages said committed cells; and ii. incubating committed cells that are engaged by said agent such that the relative number of cells expressing one or more stem cell markers increases as a result of said engaging.

REFERENCES:
patent: 5004681 (1991-04-01), Boyse et al.
patent: 5843780 (1998-12-01), Thomson
patent: 6200806 (2001-03-01), Thomson
patent: 6227202 (2001-05-01), Matapurkar
Woodle et al, (Journal of Immunology, 1997, vol. 158, pp. 2156-2164).
Pettersen et al, (Journal of Immunology, 1998, vol. 160, pp. 4343-4352).
Genestier et al (Blood, 1997, vol. 90, pp. 3626-3639.
Genestier et al (Blood, 1997, vol. 90, pp. 726-735).
Brugger et al (Blood, 1993, vol. 81, pp. 2579-2584).
Vidovic and Toral (Cancer Letter, 1998, vol. 128, pp. 127-135).
Thibeault et al (Cellular Immunology, 1999, vol. 192, pp. 79-85).
Bertho et al (Journal of Immunology, 2000, vol. 164, pp. 2379-2385).
Abstract of Tawara et al (Blood, 2001, vol. 98, pp. 250-B).
Brandt et al (Blood, 1994, vol. 83, pp. 1507-1514).
Passos-Coelho et al (Journal of Clinical Oncology, Mar. 1995, vol. 13, pp. 705-714).
Moore and Quesenberry, Leukemia, 2003, vol. 17, pp. 1205-1210.
Zhao et l, PNAS, Mar. 2003, vol. 100, pp. 2426-2431.
Yeho et al. Circulation, 2003, vol. 108, pp. 2070-2073.
Cornwell, J., “A Matter of Your Life and Death,”The Sunday Times Magazine, Feb. 1, 2004.
Abuljadayel, I.S., “Induction of Stem Cell-Like Plasticity in Mononuclear Cells Derived from Unmobilised Adult Human Peripheral Blood,”Current Medical Research and Opinion, 19(5): 355-375, 2003.
Abuljadayel, I.S. et al., “SCID Repopulating Cells Derived from Unmobilised Adult Human Peripheral Blood,”Current Medical Research and Opinion, 20(1): 87-100, 2004.
Scripps Research Institute Press Release, “Regenerative Chemical Turns Muscle Cells into Stem Cells, Say Scientists at the Scripps Research Institute”, Dec. 22, 2003.
Boral et al. Blood Preservation in Transfusion Medicine, pp. 938-846. in Henry, J., ed., Clinical Diagnosis and Management by Laboratory Methods, 18th ed., W.B. Saunders Company, Philadelphia, 1991.
Uriel, J., “Cancer, Retrodifferentiation, and the Myth of Faust”, Cancer Research 36, 4269-4275, 1976. Sato et al., Blood, 81(12): 3600-3609, Dec. 1993.
Nelson et al., “Basic Examination of Blood”, pp. 553-603 in Clinical Diagnosis & Management By Laboratory Methods, Henry, J.B. ed., W.B. Saunders Company, Philadelphia, 1991.
Nelson et al., “Hematopoiesis”, pp. 604-626, in Clinical Diagnosis & Management By Laboratory Methods, Henry, J.B., ed., W.B. Saunders Company, Philadelphia, 1991.
Ogawa et al., “Renewal and Committment to Differentiation of Hemopoietic Stem Cells (An Interpretive Review)”, Blood, vol. 61, No. 5, pp. 823-829, May 1983.
The Molecular Control of Cell Division, Differentiation Committment and Maturation in Haemopoietic Cells, vol. 339, pp. 27-30, May 1989.
Jordan et al., “Cellular and Development Properties of Fetal Hematopoietic Stem Cells”, pp. 953-963, Cell, vol. 61, Jun. 1990.
Spangrude et al., “Purification and Characterization of Mouse Hematopoietic Stem Cells”, Science, vol. 241, pp. 58-62, Jul. 1988.
Orlie et al., What Defines a Pluripotent Hematopoietic Stem Cell (PHSC): Would the Real PHSC Please Stand Up?, Blood, vol. 84, No. 12, pp. 3991-3994, Dec. 1994.
Moore et al., “Clinical Implications of Positive and Negative Hematopoietic Stem Cell Regulators”, Blood, vol. 78, pp. 1-19, Jul. 1991.
Moorehead, P.S., “Human Blood Leukocytes”, pp. 58-61, in Tissue Culture, ed. Kruse et al., Academic Press, New York, 1973.
Stedman's Medical Dictionary, 24th ed., p. 1352, Williams & Wilkens, Baltimore, 1982.
Nelson et al., “Hematopoiesis”, pp. 604-605, in Henry, J., ed., Clinical Diagnosis and Management by Laboratory Methods, 18th ed., W.B. Saunders Company, Philadelphia, 1991.
Hass, R., “Retrodifferentiation—an alternative biological pathway in human leukemia cells”, European Journal of Cell Biology, 58:1-11, 1992.
Altomonte, M., et al., “Cross-Linking of HLA Class II Antigens Modulates the Release of Tumor Necrosis Factor-.alpha. by the EBV-B Lymphoblastoid Cell Line JY,” The Journal of Immunology (151(10):5115-5122.
Cambier, J.C., et al., “Molecular Mechanisms of Transmembrane Signaling in B Lymphocytes,” in Ann Rev Imm. (1987) 5:175-199.
Cambier, J.C., et al., “Ia-Mediated Signal Transduction Leads to Proliferation of Primed B Lymphocytes,” J Exp Med (1989) 170:877-886.
Clement, L.T., et al., “Antibodies Reactive with Class II Antigens Encoded for by the Major Histocompatibility Complex inhibit human B Cell Activation,” The Journal of Immunology (1986) 136(7):2375-2381.
Deeg, H.J., et al., “Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment,” Bone Marrow Transplantation (1993) 12:425-430.
Ghaderi, A.A., et al., “Cross-linking of a sequential epitope within the .alpha.-chain of HLA-DR/DP molecules suppressing B lymphocyte growth and inducing homotypic cell aggregation,” Immunology Letters (1994) 39:113-119.
Hajeer, A.H., et al., “Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines,” Immunology (1993) 80:593-597.
Huss, R., et al., “Major Histocompatibility Complex Class II Expression is Required for Posttransplant Immunological but not for Hemopoietic Reconstitution in Mice,” Transplantation (1994) 58(12):1366-1371.
Huss, R., et al., “Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor,” Proc Natl Acad Sci USA (1995) 92:748-752.
Mooney, N., et al., “HLA Class-II Antigen-Mediated Induction of a Proliferative Response to Anti-IgM in Human B Lymphocytes,” Int J Cancer (1991) Supplement 6:30-33.
Mooney, N.A., et al., “Bacterial Superantigen Signaling via HLA Class II on Human B Lymphocytes,” Molecular Immunology (1994) 31(9):675-681.
Morio, T., et al., “Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases,” Eur J Immunol (1994) 24:651-658.
Naitoh, K., et al., “Signal Transmission through MHC Class II Molecules in a Human B Lymphoid Progenitor Cell Line: Different Signaling Pathways Depending on the Maturational Stages of B Cells,” Microbiol Immunol (1994) 38(12):967-976.
Newell, M.K., et al., “Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes,” Proc Natl Acad Sci USA (1993) 90(Nov);10459-10463.
Perl, A., et al., “Rearrangement of the T-Cell Receptor Alpha, Beta and Gamma Chain Genes in Chronic Lymphocytic Leukemia,” Leukemia Research (1990) 14(2):131-137.
Scholl, P.R., et al., “MHC class II signaling in B-cell activation,” Immunology Today (1994) 15(9):418-422.
Takahama, Y., et al., “Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation,” Eur J Immunol (1989) 19:2227-2235.
Truman, J-P., et al., “Lymphocyte programmed cell death is mediated via HLA class II DR,” International Immunology (1994) 6(6):887-896.
Wade, W.F., et al., “Structural compartmentalization of MHC class II signaling function,” Immunology Today (1993) 14(11):539-546.
J. Uriel; Cancer Research 36, 4269-4275; Nov. 1976; Cancer, Retrodifferentiation, and the Myth of Faust.
M. Fukuda; Cancer Research, 41; 4621-4628; Nov. 1981

Affiliated with

Also associated with

Rating

Method of preparing an undifferentiated cell does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of preparing an undifferentiated cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing an undifferentiated cell will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4008300